Come up with a name for your new list and we'll add to it:
Amplyx Pharmaceuticals raised a round of funding on February 09, 2016. Investors include
3x5 Special Opportunity Partners.
Amplyx Pharmaceuticals is a pre-clinical stage small molecule drug development company with a portfolio of internally discovered candidates with improved the therapeutic properties. Amplyx's platform …